Shiri Neder - 18 Mar 2026 Form 3 Insider Report for NICE Ltd. (NICE)

Role
EVP, Human Resources
Signature
/s/ Alon Levy, Attorney-in-Fact for Shiri Neder
Issuer symbol
NICE
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 09:20:09 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Neder Shiri EVP, Human Resources 221 RIVER STREET, HOBOKEN /s/ Alon Levy, Attorney-in-Fact for Shiri Neder 18 Mar 2026 0001966104

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NICE Options 18 Mar 2026 Ordinary Shares 1,800 $0.3070 Direct F1
holding NICE Options 18 Mar 2026 Ordinary Shares 3,750 $0.3142 Direct F1
holding NICE Options 18 Mar 2026 Ordinary Shares 1,200 $0.3070 Direct F1
holding NICE Options 18 Mar 2026 Ordinary Shares 2,500 $0.3142 Direct F1
holding NICE Options 18 Mar 2026 Ordinary Shares 9,150 $0.2730 Direct F2
holding NICE Options 18 Mar 2026 Ordinary Shares 9,150 $0.2718 Direct F3
holding NICE Options 18 Mar 2026 Ordinary Shares 6,100 $0.2730 Direct F4
holding NICE Options 18 Mar 2026 Ordinary Shares 4,800 $0.2706 Direct F5
holding NICE Options 18 Mar 2026 Ordinary Shares 6,100 $0.2718 Direct F6
holding NICE Options 18 Mar 2026 Ordinary Shares 10,000 $0.2824 Direct F7
holding NICE Options 18 Mar 2026 Ordinary Shares 3,200 $0.2706 Direct F8
holding NICE Options 18 Mar 2026 Ordinary Shares 12,500 $0.3228 Direct F9
holding NICE Options 18 Mar 2026 Ordinary Shares 10,000 $0.2824 Direct F10
holding NICE Options 18 Mar 2026 Ordinary Shares 10,000 $0.3228 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and currently exercisable.
F2 The stock option is vested and exercisable with respect to 6,862 Ordinary Shares and will vest with respect to the remaining shares on February 22, 2027.
F3 The stock option is vested and exercisable with respect to 4,575 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 21, 2027 and February 21, 2028.
F4 The stock option is vested and exercisable with respect to 4,575 Ordinary Shares and will vest with respect to the remaining shares on February 22, 2027.
F5 The stock option is vested and exercisable with respect to 2,400 Ordinary Shares and will vest with respect to the remaining shares on June 1, 2027.
F6 The stock option is vested and exercisable with respect to 3,050 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 21, 2027 and February 21, 2028.
F7 The stock option is vested and exercisable with respect to 2,500 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on February 19, 2027, February 19, 2028 and February 19, 2029.
F8 The stock option is vested and exercisable with respect to 1,600 Ordinary Shares and will vest with respect to the remaining shares on June 1, 2027.
F9 The stock option will vest in substantially equal installments on February 18, 2027, February 18, 2028, February 18, 2029 and February 18, 2030.
F10 The stock option is vested and exercisable with respect to 2,500 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 19, 2027, February 19, 2028 and February 19, 2029
F11 Each Option represents a contingent right to receive one Ordinary Share of the Issuer. The Options are eligible to vest over a three-year performance period ending February 18, 2029, subject to adjustments in accordance with the terms of the awards, based upon the Issuer?s achievement of specified stock price performance thresholds.

Remarks:

Exhibit 24 - Power of Attorney.